News 07.03.18

Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors

Aduro Biotech announced that the company earned a $3.0 million development milestone payment under its worldwide licensing agreement with Merck for the initiation of a Phase I clinical trial of its anti-CD27 antibody.

Read more
News 01.03.18

Brigitte Drees nieuwe directeur Pivot Park

Brigitte Drees volgt Mirjam Mol-Arts op, welke 1 januari afscheid nam van het Pivot Park.

Read more
News 27.02.18

RA2day: addressing today’s regulatory topics

Zwiers Regulatory Consultancy is organising RA2day on April 13th 2018.

Read more
News 08.02.18

Over 50 companies based at Pivot Park!

Recently the number of companies based at Pivot Park reached the milestone of 50!

Read more
News 08.02.18

New at Pivot Park – PharmaCytics

PharmaCytics offers a drug delivery solution, based on an advanced prodrug approach.

Read more
News 25.01.18

InnatOss and MediSapiens Receive EU Grant to Personalize Lyme Diagnostics

Recently the number of companies based at Pivot Park reached the milestone of 50!

Read more
News 11.01.18

New at Pivot Park – Sterk Schakelen

Sterk Schakelen is now a member of the Pivot Park Community.

Read more
News 13.12.17

New at Pivot Park – CheckMark Labrecruitment

Since December 1st Checkmark Labrecruitment is present at Pivot Park.

Read more
News 11.12.17

ImmunoPrecise to Acquire ModiQuest Research BV

IMMUNOPRECISE ANTIBODIES LTD. announces that it has signed a binding letter of intent with ModiQuest Research BV.

Read more